Clinical trial
A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics…
NCT00409929 · Novartis, Industry · Completed
Key facts
| NCT number | NCT00409929 |
|---|---|
| Title | A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics of AEB071 |
| Official title | A Randomized, Double-blind, Placebo-controlled, Time Lagged, Parallel Group, Ascending Single Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Oral AEB071 Doses Greater Than 500 mg in Healthy Subjects |
| Lead sponsor | Novartis, Industry |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Healthy |
| Intervention type | Drug |
| Interventions | AEB071 |
| Enrollment | 16 |
| Start date | Jun 1, 2006 |
| Primary completion | Jul 1, 2006 |
| First posted | Dec 12, 2006 |
| Last update posted | Oct 19, 2010 |
| Countries | Switzerland |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: